These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34215700)

  • 1. Progressive supranuclear palsy: diagnosis and management.
    Rowe JB; Holland N; Rittman T
    Pract Neurol; 2021 Oct; 21(5):376-383. PubMed ID: 34215700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnosis of progressive supranuclear palsy: current opinions and challenges.
    Ali F; Josephs K
    Expert Rev Neurother; 2018 Jul; 18(7):603-616. PubMed ID: 29902389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive supranuclear palsy.
    Esper CD; Weiner WJ; Factor SA
    Rev Neurol Dis; 2007; 4(4):209-16. PubMed ID: 18195676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive supranuclear palsy: current approach and challenges to diagnosis and treatment.
    Veilleux Carpentier A; McFarland NR
    Curr Opin Neurol; 2023 Aug; 36(4):309-316. PubMed ID: 37381926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia.
    Kanazawa M; Tada M; Onodera O; Takahashi H; Nishizawa M; Shimohata T
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1149-51. PubMed ID: 23916652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of progressive supranuclear palsy.
    Litvan I
    Semin Neurol; 2001; 21(1):41-8. PubMed ID: 11346024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive supranuclear palsy.
    Kent A
    Nurs Stand; 2013 Aug 21-27; 27(51):48-57; quiz 58. PubMed ID: 23965099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease course and treatment patterns in progressive supranuclear palsy: A real-world study.
    Morgan JC; Ye X; Mellor JA; Golden KJ; Zamudio J; Chiodo LA; Bao Y; Xie T
    J Neurol Sci; 2021 Feb; 421():117293. PubMed ID: 33385754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phenotypic spectrum of progressive supranuclear palsy.
    Respondek G; Höglinger GU
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S34-6. PubMed ID: 26421392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
    Litvan I; Mangone CA; McKee A; Verny M; Parsa A; Jellinger K; D'Olhaberriague L; Chaudhuri KR; Pearce RK
    J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):615-20. PubMed ID: 8648326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive supranuclear palsy: a current review.
    Lubarsky M; Juncos JL
    Neurologist; 2008 Mar; 14(2):79-88. PubMed ID: 18332837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of allied health therapy in the symptomatic management of progressive supranuclear palsy: a systematic review.
    Tilley E; McLoughlin J; Koblar SA; Doeltgen SH; Stern C; White S; Peters MD
    JBI Database System Rev Implement Rep; 2016 Jun; 14(6):148-95. PubMed ID: 27532657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinicopathological study of vascular progressive supranuclear palsy: a multi-infarct disorder presenting as progressive supranuclear palsy.
    Josephs KA; Ishizawa T; Tsuboi Y; Cookson N; Dickson DW
    Arch Neurol; 2002 Oct; 59(10):1597-601. PubMed ID: 12374498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive supranuclear palsy: Advances in diagnosis and management.
    Coughlin DG; Litvan I
    Parkinsonism Relat Disord; 2020 Apr; 73():105-116. PubMed ID: 32487421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on progressive supranuclear palsy.
    Litvan I
    Curr Neurol Neurosci Rep; 2004 Jul; 4(4):296-302. PubMed ID: 15217544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontal presentation in progressive supranuclear palsy.
    Donker Kaat L; Boon AJ; Kamphorst W; Ravid R; Duivenvoorden HJ; van Swieten JC
    Neurology; 2007 Aug; 69(8):723-9. PubMed ID: 17709703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy.
    Moccia M; Picillo M; Erro R; Allocca R; Barone P; Vitale C
    J Neurol Sci; 2015 Mar; 350(1-2):103-4. PubMed ID: 25697711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progressive supranuclear palsy: what's new?].
    Levy R
    Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):191-201. PubMed ID: 21690028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive supranuclear palsy: new concepts.
    Barsottini OG; Felício AC; Aquino CC; Pedroso JL
    Arq Neuropsiquiatr; 2010 Dec; 68(6):938-46. PubMed ID: 21243256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
    Litvan I; Campbell G; Mangone CA; Verny M; McKee A; Chaudhuri KR; Jellinger K; Pearce RK; D'Olhaberriague L
    Brain; 1997 Jan; 120 ( Pt 1)():65-74. PubMed ID: 9055798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.